A DECISION MODELING APPROACH TO EVALUATE THE COST-EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH PLANNED PERCUTANEOUS CORONARY INTERVENTION

被引：1
|
作者：
Rao, S. [1 ]
Lin, F. J. [1 ]
Ojo, O. [1 ]
Patel, V [1 ]
Yu, S. [1 ]
Zhan, L. [1 ]
Touchette, D. R. [1 ]
机构：
[1] Univ Illinois, Chicago, IL USA
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
10.1016/j.jval.2011.02.229
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A39 / A40
页数：2
相关论文
共 50 条
  • [41] Prasugrel in Clopidogrel Nonresponders A Way to Improve Secondary Prevention in Patients After Percutaneous Coronary Intervention?
    Huber, Kurt
    JACC-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (12) : 1571 - 1573
  • [42] Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention
    Venetsanos, Dimitrios
    Traff, Erik
    Erlinge, David
    Hagstrom, Emil
    Nilsson, Johan
    Desta, Liyew
    Lindahl, Bertil
    Mellbin, Linda
    Omerovic, Elmir
    Szummer, Karolina Elisabeth
    Zwackman, Sammy
    Jernberg, Tomas
    Alfredsson, Joakim
    HEART, 2021, 107 (14) : 1145 - 1151
  • [43] Short-term Safety and Mid-term Efficacy of Prasugrel Versus Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention
    Koyabu, Yota
    Abe, Shichiro
    Sakuma, Masashi
    Kanaya, Tomoaki
    Obi, Syotaro
    Yonede, Shuichi
    Toyoda, Shigeru
    Nakajima, Toshiaki
    Inoue, Teruo
    INTERNAL MEDICINE, 2019, 58 (16) : 2315 - 2322
  • [44] Long-term use of clopidogrel versus ticagrelor or prasugrel in patients with acute myocardial infarction after percutaneous coronary intervention
    Kim, Yuri
    Jeong, Myung Ho
    An, Minjeong
    Cho, Kyunghoon
    Hong, Youngjoon
    Kim, Juhan
    Ahn, Youngkeun
    PLOS ONE, 2023, 18 (02):
  • [45] Cost-Effectiveness of Multigene Pharmacogenetic Testing in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention
    Dong, Olivia M.
    Wheeler, Stephanie B.
    Cruden, Gracelyn
    Lee, Craig R.
    Voora, Deepak
    Dusetzina, Stacie B.
    Wiltshire, Tim
    VALUE IN HEALTH, 2020, 23 (01) : 61 - 73
  • [46] Safety of Reloading Prasugrel in Addition to Clopidogrel Loading in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Loh, Joshua P.
    Pendyala, Lakshmana K.
    Kitabata, Hironori
    Torguson, Rebecca
    Chen, Fang
    Kent, Kenneth M.
    Satler, Lowell F.
    Suddath, William O.
    Pichard, Augusto D.
    Waksman, Ron
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (06): : 841 - 845
  • [47] Genetic testing in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a cost-effectiveness analysis
    Lala, A.
    Berger, J. S.
    Sharma, G.
    Hochman, J. S.
    Braithwaite, R. Scott
    Ladapo, J. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (01) : 81 - 91
  • [48] Ticagrelor Versus Prasugrel in Acute Coronary Syndrome Patients With High On-Clopidogrel Platelet Reactivity Following Percutaneous Coronary Intervention A Pharmacodynamic Study
    Alexopoulos, Dimitrios
    Galati, Anastasia
    Xanthopoulou, Ioanna
    Mavronasiou, Eleni
    Kassimis, George
    Theodoropoulos, Konstantinos C.
    Makris, George
    Damelou, Anastasia
    Tsigkas, Grigorios
    Hahalis, George
    Davlouros, Periklis
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (03) : 193 - 199
  • [49] Effects of prasugrel versus clopidogrel on coronary microvascular function in patients undergoing elective percutaneous coronary intervention: a randomized double-blind study
    Mangiacapra, F.
    Pellicano, M.
    Di Serafino, L.
    Bressi, E.
    Peace, A.
    Di Gioia, G.
    Bartunek, J.
    Wijns, W.
    De Bruyne, B.
    Barbato, E.
    EUROPEAN HEART JOURNAL, 2015, 36 : 682 - 682
  • [50] The cost-effectiveness of fluvastatin in hungary following successful percutaneous coronary intervention
    Scuffham, Paul A.
    Kosa, Jozsef
    CARDIOVASCULAR DRUGS AND THERAPY, 2006, 20 (04) : 309 - 317
12345